Please ensure Javascript is enabled for purposes of website accessibility

Galectin Therapeutics(GALT)

Nasdaq Capital Market (Nasdaq)

Galectin Therapeutics Stock Quote
$3.17 $0.02 0.6%
Price as of August 5, 2021, 11:51 a.m. ET View Interactive GALT Charts

A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.

Interactive Chart

Compare GALT Stock to Peers

Symbol Last Price Market Cap % Δ 1 Yr % Δ 5 Yr
Galectin Therapeutics
$3.17 $183M 23.0% 53.7%
$0.32 $48M 7.4%
$0.00 $5MM -50.0%
$0.24 $209M 0.0%
$7.51 $95M 22.5% -14.9%

News & Analysis: Galectin Therapeutics


Market Moves

Why Galectin Therapeutics Inc. Shares Jumped

Galectin shares soar following the company's dosing of its first patient in a second phase 1 cohort. Here's what shareholders should really be watching.

Why Galectin Therapeutics, Inc. Shares Soared

Galectin sets the date for the release of its phase 1 study data on GR-MD-02 for nonalcoholic steatohepatitis. Find out what shareholders should really be waiting for.